More than 90% of the companies in the S&P 500 (^GSPC) have reported their earnings for the first quarter of 2024, which yielded a mostly strong result for the index. However, Bristol-Myers Squibb (BMY) posted its quarterly earnings, resulting in a massive drag on the S&P. According to data from FactSet, the gains for the S&P were cut from 8.3% to 5.4% when Squibb's earnings were included.
Yahoo Finance Reporter Josh Schafer joins The Morning Brief to analyze Bristol-Myers Squibb's earnings in relation to the S&P and its impacts on the overall market.
For more expert insight and the latest market action, click here to watch this full episode of Morning Brief.
This post was written by Nicholas Jacobino